Everand Logo

Welcome to Everand!

  • STAT

    Opinion: State drug importation laws undermine the process that keeps our supply chain safe

    State legislators seem dangerously ill-informed about their states' troubled history of counterfeit drugs and are recreating the chaos that preceded the passage of a national track-and-trace system for prescription drugs.
    by Adam J. Fein and Dirk Rodgers Jul 11, 2019 5 minutes

    Three states — Vermont, Florida, and Colorado — recently passed laws that legalize the importation of prescription drugs. Other states are considering similar legislation. Legislators in those states believe that drugs can be safely sourced from Canada at costs lower than U.S. prices.

    These new state laws conflict with and undermine our country’s in-progress national legislative and regulatory system for tracking and tracing drugs. This system was established six years ago to stop counterfeit drugs from entering the U.S. supply chain. We estimate that manufacturers, wholesalers, and pharmacies will ultimately spend billions to build this system, which is scheduled to be fully operational by 2023.

    The U.S. track-and-trace system is designed to prevent the very problems that misguided state importation laws will create. It’s curious that Florida wants to bypass this system, given its notorious and troubled history with counterfeit and diverted drugs.

    As experts in drug distribution, we believe that politicians are

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

    Related Books & Audiobooks